BRIGHT MINDS BIOSCIENCES CLOSES US$35 MILLION NON-BROKERED PRIVATE PLACEMENT
Vancouver, British Columbia, November 4, 2024 – Bright Minds Biosciences Inc. (CSE:DRUG) (NASDAQ: DRUG) (“Bright Minds” or the “Company”)announcesthat further to its news release of October 18, 2024, the Company has closed a non-brokered private placement of1,612,902common shares in the capital of the Company (“Shares”) at a price of USD$21.70 per Sharefor aggregate gross proceeds…